当前位置: 首页 > 详情页

Occurrence of composite cardiac endpoints with change in resting heart rate among Chinese patients with coronary artery disease: Chinese cohort from the real-world BISO-CAD study

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Cardiology, China PLA General Hospital, Beijing, China [2]Department of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China [3]Affiliated Hospital of Guangdong Medical College, China [4]Sir Run Run Shaw Hospital Affiliated with School of Medicine, Zhejiang University, China [5]West China Hospital, China [6]The Second Xiangya Hospital of Central South University, China [7]Shanghai First People’s Hospital, China [8]Merck Serono China R&D, Beijing, China [9]Merck Serono Co. Ltd., Beijing, China [10]First Affiliated Hospital of Dalian Medical University, China [11]Affiliated Hospital of North Sichuan Medical College, China [12]Fu Xing Hospital, Capital Medical University, China [13]Zhongnan Hospital of Wuhan University, China [14]Xuanwu Hospital Capital Medical University, China [15]The First Affiliated Hospital of the Fourth Military Medical University, China [16]Chinese Armed Police Force General Hospital, China [17]PLA, the Military General Hospital of Beijing, China [18]The Second Affiliated Hospital of the Fourth Military Medical University, China [19]The First People’s Hospital of Hangzhou, China [20]The People’s Hospital of Zhongshan City, China [21]Beijing Anzhen Hospital Capital Medical University, China [22]Xiangya Hospital of Central South University, China
出处:
ISSN:

关键词: Resting heart rate coronary heart disease bisoprolol Chinese cohort composite cardiac endpoint

摘要:
Objective: We evaluated change in resting heart rate (RHR) and its impact on prognosis in Chinese coronary artery disease (CAD) patients treated with bisoprolol, and also assessed drug safety and tolerability. Methods: This phase IV, single arm observational study was a sub-study of the BISO-CAD study conducted across 20 hospitals in China between October 2011 and July 2015 with follow-up at 6, 12 and 18 months after baseline. The primary endpoint was occurrence of composite cardiac events. Results: A total of 663 CAD patients (baseline RHR 75.47 +/- 6.62 bpm) were enrolled in the intent-to-treat (ITT) set, and 513 patients were included in the efficacy analysis (EA) set. In the ITT set, the risk and the number of composite cardiac events in patients with mean RHR 69-74 bpm were significantly higher than in the <65 bpm group (ITT: estimate 1.03 +/- 0.47, p = .029). The incidence of the composite cardiac endpoint was not affected by continuous mean RHR (p = .5070). RHR significantly decreased from baseline to 18 months, most obviously in the first 6 months (p < .0001). Ejection fraction and fractional shortening significantly improved in both the ITT and EA sets. An average RHR of 69-74 bpm had a significant effect on admission to hospital for acute coronary syndrome in the ITT (estimate 1.10, HR 3.004, p = .0196) and EA (estimate 1.26, HR 3.526, p = .0132) groups. Seven (1.1%) patients reported drug related adverse events. Conclusion: Reduction in RHR with bisoprolol lowered the incidence of composite cardiac events along with an acceptable safety and tolerability profile.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科 3 区 医学:研究与实验
最新[2023]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科 4 区 医学:研究与实验
JCR分区:
出版当年[2016]版:
Q1 MEDICINE, GENERAL & INTERNAL Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL Q3 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Cardiology, China PLA General Hospital, Beijing, China
通讯作者:
通讯机构: [1]Department of Cardiology, China PLA General Hospital, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院